ASCO: AffyImmune builds up foundations of autologous CAR T cell therapy
In spite of their potential to tackle cancer in the long term, CAR-T cell therapies face challenges in terms of pricing, manufacturing and being limited to blood cancer.
Archives for June 11, 2024
Oligonucleotides in the spotlight as GSK snaps up RNA startup for up to $50 million
GSK has acquired its San Diego-based collaborator Elsie Biotechnologies to strengthen its efforts in developing oligonucleotide therapeutics.
Kyowa Kirin to set up $530 million biologics production facility in North Carolina
Keen to accelerate its drug development, the Japanese pharmaceutical group Kyowa Kirin will pump up to $530 million into building a biologics manufacturing plant in North Carolina, US.
Is Combogesic IV revolutionizing pain management in the US healthcare market?
Hikma Pharmaceuticals PLC has made a significant announcement, marking the US launch of Combogesic IV, an intravenous, opioid-free pain relief medication providing a multimodal approach to managing pain in adults.